CymaBay Therapeutics (NASDAQ:CBAY – Free Report) and VYNE Therapeutics (NASDAQ:VYNE – Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability. Analyst Recommendations This is a summary of recent recommendations […]